[1]ACSMedicinalChemistryLetters,2012,vol.3,#3,p.232-237
[2]Patent:US9422262,2016,B2,.Locationinpatent:Page/Pagecolumn33;34;35
[1]ACSMedicinalChemistryLetters,2012,vol.3,#3,p.232-237
[2]Patent:US9422262,2016,B2,
[1]ACSMedicinalChemistryLetters,2012,vol.3,#3,p.232-237
Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.
Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
Title: Gandhi DM, et al. Characterization of Protease-Activated Receptor (PAR) ligands: Parmodulins are reversible allosteric inhibitors of PAR1-driven calcium mobilization in endothelial cells. Bioorg Med Chem. 2018 May 15;26(9):2514-2529.
Title: Susanna F Gunnink, et al. Allosteric inhibition of protease activated receptor 1: a new antiplatelet therapy.
Title: Aisiku O, et al. Parmodulins inhibit thrombus formation without inducing endothelial injury caused by vorapaxar. Blood. 2015 Mar 19;125(12):1976-85.